Pregled bibliografske jedinice broj: 831880
Chemokine receptor profile of osteoclast progenitor cells in patients with rheumatoid arthritis
Chemokine receptor profile of osteoclast progenitor cells in patients with rheumatoid arthritis // IBMS BoneKey / Ferrari, Serge (ur.).
Rotterdam, Nizozemska: Macmillan, 2015. str. 4-5 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 831880 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Chemokine receptor profile of osteoclast progenitor cells in patients with rheumatoid arthritis
Autori
Šućur, Alan ; Jajić, Zrinka ; Artuković, Marinko ; Stipić Marković, Asja ; Kovačić, Nataša ; Zrinski Petrović, Katerina ; Ivčević, Sanja ; Grčević, Danka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
IBMS BoneKey
/ Ferrari, Serge - : Macmillan, 2015, 4-5
Skup
4th Joint Meeting of European Calcified Tissue Society (ECTS) and the International Bone and Mineral Society (IBMS)
Mjesto i datum
Rotterdam, Nizozemska, 25.04.2015. - 28.04.2015
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
osteoclast progenitors ; rheumatoid arthritis
Sažetak
Introduction. Rheumatoid arthritis (RA) is a chronic joint disease marked by persistent inflammation and osteodestruction. The mechanisms leading to joint destruction involve infiltration of osteoclasts, multinucleated cells derived from monocyte/macrophage lineage. Human osteoclast progenitors (OCPs) are contained among peripheral blood monocytes at low frequency even in healthy subjects. OCPs exhibit chemotaxis and, furthermore, synovial compartment of RA patients highly express different chemokines. The aim of our study was to define these chemotactic signals by analyzing expression of several chemokine receptors on OCPs in the peripheral blood, the levels of their respective ligands in serum and synovial fluid of RA patients and to assess differentiation potential of isolated OCPs. Methods. Mononuclear cells were separated from peripheral blood of healthy controls and RA patients. The phenotype of OCPs (CD3- CD19-CD56- CD11b+CD14+) was determined using flow cytometry for the following chemokine receptors: C5AR1, CCR1, CCR2, CCR4, CXCR4. Chemokine ligand concentrations (MIP-1α/CCL3, MIP-1β/CCL4, MCP- 1/CCL2, RANTES/CCL5) were measured in serum and synovial fluid of RA patients using flow cytometry bead based array. OCPs were sorted and cultured with M-CSF and RANKL. After two weeks, the cells were stained for TRAP enzyme and positive, mature, osteoclasts were counted. Results. Human peripheral blood OCPs similarly expressed chemokine receptors CCR1, CCR2, CCR4 and CXCR4 in RA and healthy subjects. However, MCP- 1/CCL2, MIP1a/CCL3 and MIP1b/CCL4 concentrations were significantly higher in synovial fluid, as well as CCL2 and CCL4 in serum. Cell culture revealed no significant differences in mature osteoclast count between RA and control group. Conclusions. Although OCPs in RA have a differentiation potential similar to controls, levels of several chemokines are upregulated, indicating a possible chemotactic mechanism of OCP migration to affected joints. These results may help to reveal a migration mechanism of OCPs specifically associated with RA in order to develop more efficient therapeutic approaches.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Nataša Kovačić
(autor)
Zrinka Jajić
(autor)
Sanja Ivčević
(autor)
Danka Grčević
(autor)
Alan Šućur
(autor)
Asja Stipić Marković
(autor)